Systematic mediastinal lymph node dissection (LND) or sampling is currently recommended for patients with early-stage non–small cell lung cancer. We aimed to investigate whether no mediastinal LND was ...
In a 2024 Journal of Thoracic Oncology review, Haiquan Chen, MD, PhD, of Fudan University Shanghai Cancer Center in China, and colleagues backed the use of selective lymph node dissection (LND) to ...
Final results of a phase II study of sunitinib as second-line therapy in malignant pleural mesothelioma (MPM). Background: Given the cytostatic nature of molecular targeted agents, the response to ...
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study We conducted a multicenter, open-label, ...
bioAffinity Technologies’ noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to confirmed malignancy and immediate treatment Ground-glass nodules appear in ...
bioAffinity Technologies’ noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to confirmed malignancy and immediate treatment SAN ANTONIO--(BUSINESS WIRE)-- ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback